These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2684714

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.
    Nolan JJ, Ludvik B, Baloga J, Reichart D, Olefsky JM.
    Diabetes; 1997 Jun; 46(6):994-1000. PubMed ID: 9166671
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Changes in glucose disposal and cellular insulin binding in obese black Southern African patients with type 2 diabetes mellitus before and after sulphonylurea therapy.
    Wing JR, Panz VR, Joffe BI, Seftel HC.
    Diabet Med; 1993 Jun; 10(1):50-5. PubMed ID: 8435988
    [Abstract] [Full Text] [Related]

  • 30. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G, Di Garbo V, Cordova R, Rotolo G, Abruzzese G, Raneli G, De Simone R, Bompiani GD.
    Diabetes Res; 1994 Jun; 25(2):85-92. PubMed ID: 7648783
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE, Halban PA.
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [Abstract] [Full Text] [Related]

  • 33. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ.
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
    Garvey WT, Olefsky JM, Rubenstein AH, Kolterman OG.
    Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM.
    Sinha MK, Pories WJ, Flickinger EG, Meelheim D, Caro JF.
    Diabetes; 1987 May; 36(5):620-5. PubMed ID: 3032715
    [Abstract] [Full Text] [Related]

  • 38. Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDM.
    Polonsky KS, Gumbiner B, Ostrega D, Griver K, Tager H, Henry RR.
    Diabetes; 1994 Jul; 43(7):871-7. PubMed ID: 8013750
    [Abstract] [Full Text] [Related]

  • 39. Effect of NIDDM on the kinetics of whole-body protein metabolism.
    Gougeon R, Pencharz PB, Marliss EB.
    Diabetes; 1994 Feb; 43(2):318-28. PubMed ID: 8288057
    [Abstract] [Full Text] [Related]

  • 40. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P, Brismar K, Rosenfeld RG, Hall K.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.